Task Force Chair Welcome

Dear Colleague:

It is a pleasure to welcome you on behalf of the CEO Roundtable on Cancer to its Life Sciences Consortium (LSC) website.

The Life Sciences Consortium was formed as a Task Force of the CEO Roundtable to catalyze CEO Roundtable companies invested in the life sciences to forge collaborations that focus on solving issues common to cancer medicine that cannot be solved by any corporation or institution working alone.

We invite you to use the resources provided on this site as we collaboratively work to hasten the discovery of novel and more effective anti-cancer therapies as well as improved diagnostic tools.

We value your insight and feedback as together we work to benefit cancer patients worldwide.

Sincerely,
TaskForceChairSig.gif
Dr. Gregory A. Curt 
Chair, Life Sciences Consortium
Gregory.Curt@astrazeneca.com 

October 10 2008
CEO Roundtable on Cancer Offers “Common Language” to Jump Start Cancer Clinical Trials
- Partnership with National Cancer Institute, academic centers and industry could speed new therapies to cancer patients -
Read More

Standard Terms of Agreement for Research Trial (START) Clauses

StartCover.png Access to standardized legal language for Key elements can increase the efficiency of contract negotiations, resulting in reduced costs and accelerating the entry of new therapies into clinical trials.

Print Page Email Page to Friend Feedback
© 2010 by Life Sciences Consortium  All rights reserved.